A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Eli Lilly & CO stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 36,349 shares of LLY stock, worth $32.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
36,349
Previous 30,581 18.86%
Holding current value
$32.9 Million
Previous $16.4 Million 72.16%
% of portfolio
0.31%
Previous 0.2%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $3.42 Million - $4.57 Million
5,768 Added 18.86%
36,349 $28.3 Million
Q3 2023

Nov 08, 2023

SELL
$434.7 - $599.3 $388,187 - $535,174
-893 Reduced 2.84%
30,581 $16.4 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $330,046 - $441,310
941 Added 3.08%
31,474 $14.8 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $100,022 - $117,472
-322 Reduced 1.04%
30,533 $10.5 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $3.78 Million - $4.41 Million
11,759 Added 61.58%
30,855 $11.3 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $215,244 - $245,293
726 Added 3.95%
19,096 $6.18 Million
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $151,907 - $178,362
-545 Reduced 2.88%
18,370 $5.96 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $52,805 - $65,623
-225 Reduced 1.18%
18,915 $5.42 Million
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $28,106 - $34,880
-125 Reduced 0.65%
19,140 $5.29 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $158,222 - $194,714
-714 Reduced 3.57%
19,265 $4.45 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $219,548 - $283,984
-1,216 Reduced 5.74%
19,979 $4.59 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $13,638 - $17,655
83 Added 0.39%
21,195 $3.96 Million
Q4 2020

Feb 05, 2021

SELL
$130.46 - $172.63 $181,600 - $240,300
-1,392 Reduced 6.19%
21,112 $3.57 Million
Q3 2020

Nov 06, 2020

BUY
$146.22 - $169.13 $28,074 - $32,472
192 Added 0.86%
22,504 $3.33 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $736,667 - $886,572
-5,400 Reduced 19.49%
22,312 $3.66 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $226,195 - $279,965
-1,900 Reduced 6.42%
27,712 $3.84 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $387,585 - $480,058
-3,625 Reduced 10.91%
29,612 $3.89 Million
Q3 2019

Nov 01, 2019

SELL
$106.79 - $116.16 $128,148 - $139,392
-1,200 Reduced 3.48%
33,237 $3.72 Million
Q2 2019

Aug 02, 2019

BUY
$110.79 - $129.32 $1.03 Million - $1.2 Million
9,300 Added 37.0%
34,437 $3.82 Million
Q1 2019

May 02, 2019

SELL
$111.31 - $131.02 $1.24 Million - $1.45 Million
-11,103 Reduced 30.64%
25,137 $3.26 Million
Q4 2018

Jan 30, 2019

SELL
$105.9 - $118.64 $479,197 - $536,846
-4,525 Reduced 11.1%
36,240 $4.19 Million
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $734,103 - $917,500
-8,550 Reduced 17.34%
40,765 $4.37 Million
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $123,769 - $142,048
-1,635 Reduced 3.21%
49,315 $4.21 Million
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $85,341 - $100,740
-1,150 Reduced 2.21%
50,950 $3.94 Million
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $1.78 Million - $1.91 Million
-21,750 Reduced 29.45%
52,100 $4.4 Million
Q3 2017

Nov 01, 2017

BUY
$77.07 - $85.54 $5.69 Million - $6.32 Million
73,850
73,850 $6.32 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.